{
"info": {
"nct_id": "NCT03641560",
"official_title": "A Multicenter Phase 4, Open-label, Single-arm, Safety and Efficacy Study of Enzalutamide in Indian Patients With Progressive Metastatic Castration-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel-Based Chemotherapy",
"inclusion_criteria": "* Subject is diagnosed with histologically or cytologically confirmed adenocarcinoma of the prostate without neuroendocrine differentiation, signet cell or small cell histology.\n* Subject with established diagnosis of metastatic castration-resistant prostate carcinoma.\n* Subject is being newly initiated on Xtandi treatment (Enzalutamide).\n* Subject has an estimated life expectancy of ≥ 6 months.\n* Subject agrees not to participate in another interventional study while participating in the present study.\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Subject who is not eligible to receive Xtandi as per the locally approved prescribing information.\n* Subject participating or planning to participate in any interventional drug trial during the course of this trial.\n* Subject has received investigational study within 28 days or 5 half-lives, whichever is longer, prior to screening.\n* Subject has any condition which makes the subject unsuitable for study participation.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Subject is diagnosed with histologically or cytologically confirmed adenocarcinoma of the prostate without neuroendocrine differentiation, signet cell or small cell histology.",
"criterions": [
{
"exact_snippets": "diagnosed with histologically or cytologically confirmed adenocarcinoma of the prostate",
"criterion": "adenocarcinoma of the prostate",
"requirements": [
{
"requirement_type": "confirmation method",
"expected_value": [
"histologically",
"cytologically"
]
}
]
},
{
"exact_snippets": "without neuroendocrine differentiation",
"criterion": "neuroendocrine differentiation",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "without ... signet cell ... histology",
"criterion": "signet cell histology",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "without ... small cell histology",
"criterion": "small cell histology",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Subject with established diagnosis of metastatic castration-resistant prostate carcinoma.",
"criterions": [
{
"exact_snippets": "established diagnosis of metastatic castration-resistant prostate carcinoma",
"criterion": "metastatic castration-resistant prostate carcinoma",
"requirements": [
{
"requirement_type": "diagnosis",
"expected_value": true
}
]
}
]
},
{
"line": "* Subject is being newly initiated on Xtandi treatment (Enzalutamide).",
"criterions": [
{
"exact_snippets": "Subject is being newly initiated on Xtandi treatment (Enzalutamide)",
"criterion": "Xtandi treatment (Enzalutamide)",
"requirements": [
{
"requirement_type": "initiation status",
"expected_value": "newly initiated"
}
]
}
]
},
{
"line": "* Subject has an estimated life expectancy of ≥ 6 months.",
"criterions": [
{
"exact_snippets": "estimated life expectancy of ≥ 6 months",
"criterion": "life expectancy",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 6,
"unit": "months"
}
}
]
}
]
},
{
"line": "* Subject agrees not to participate in another interventional study while participating in the present study.",
"criterions": [
{
"exact_snippets": "Subject agrees not to participate in another interventional study",
"criterion": "participation in another interventional study",
"requirements": [
{
"requirement_type": "agreement",
"expected_value": false
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must be MALE",
"criterions": [
{
"exact_snippets": "Must be MALE",
"criterion": "gender",
"requirements": [
{
"requirement_type": "expected_value",
"expected_value": "male"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Subject who is not eligible to receive Xtandi as per the locally approved prescribing information.",
"criterions": [
{
"exact_snippets": "not eligible to receive Xtandi as per the locally approved prescribing information",
"criterion": "eligibility to receive Xtandi",
"requirements": [
{
"requirement_type": "eligibility",
"expected_value": false
}
]
}
]
},
{
"line": "* Subject participating or planning to participate in any interventional drug trial during the course of this trial.",
"criterions": [
{
"exact_snippets": "Subject participating ... in any interventional drug trial",
"criterion": "participation in interventional drug trial",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "planning to participate in any interventional drug trial",
"criterion": "planned participation in interventional drug trial",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Subject has received investigational study within 28 days or 5 half-lives, whichever is longer, prior to screening.",
"criterions": [
{
"exact_snippets": "Subject has received investigational study within 28 days or 5 half-lives, whichever is longer, prior to screening.",
"criterion": "receipt of investigational study",
"requirements": [
{
"requirement_type": "time since last dose",
"expected_value": {
"comparisons": [
{
"operator": ">",
"value": 28,
"unit": "days"
}
]
}
}
]
}
]
},
{
"line": "* Subject has any condition which makes the subject unsuitable for study participation.",
"criterions": [
{
"exact_snippets": "any condition which makes the subject unsuitable for study participation",
"criterion": "suitability for study participation",
"requirements": [
{
"requirement_type": "suitability",
"expected_value": true
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}